Robust Glucose Control and Weight Loss after Six Weeks of Treatment with MEDI0382, a Balanced GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes

Authors
Category Primary study
ConferenceDiabetes
Year 2018
This article has no abstract
Epistemonikos ID: b4e7824d175bc1ad20c06e18a119b369498abe7e
First added on: Apr 04, 2026